Identification
B: Ultraviolet Absorption 197U
Solution:
250 µg per mL.
Medium:
0.1 N sodium hydroxide.
Respective absorptivities at 264 nm and 273 nm, calculated on the anhydrous basis, do not differ by more than 3.0%.
C:
The chromatogram of the Assay preparation obtained as directed in the Assay exhibits a major peak for ibuprofen, the retention time of which, relative to that of the internal standard, corresponds to that exhibited in the chromatogram of the Standard preparation, obtained as directed in the Assay.
Chromatographic purity
Mobile phase
Prepare a suitable filtered mixture of water, previously adjusted with phosphoric acid to a pH of 2.5 and acetonitrile (1340:680). Make adjustments if necessary (see
System Suitability under
Chromatography 621).
Test preparation
Prepare a solution of Ibuprofen in acetonitrile containing about 5 mg per mL.
Resolution solution
Prepare a solution in acetonitrile containing in each mL about 5 mg of Ibuprofen and 5 mg of valerophenone.
Chromatographic system (see Chromatography 621)
The liquid chromatograph is equipped with a 214-nm detector and a 4-mm × 15-cm column that contains 5-µm packing L1 and is maintained at 30 ± 0.2
. The flow rate is about 2 mL per minute. Chromatograph a series of 5-µL injections of the
Test preparation to condition the column. Chromatograph the
Resolution solution, and record the peak responses as directed for
Procedure: the relative retention times are about 0.8 for valerophenone and 1.0 for ibuprofen, and the resolution,
R, between the valerophenone peak and the ibuprofen peak is not less than 2.0.
Procedure
[NOTEUse peak areas where peak responses are indicated.
] Inject about 5 µL of the
Test preparation into the chromatograph, record the chromatogram, and measure the peak responses. Calculate the percentage of each impurity taken by the formula:
100ri / rt,
in which
ri is the response of an individual peak, other than the solvent peak and the main ibuprofen peak, and
rt is the sum of the responses of all the peaks, excluding that of the solvent peak: not more than 0.3% of any individual impurity is found, and the sum of all the individual impurities found does not exceed 1.0%.
Limit of 4-isobutylacetophenone
Using the chromatograms of the
Assay preparation and the
4-Isobutylacetophenone standard solution obtained as directed in the
Assay, calculate the percentage of 4-isobutylacetophenone (C
12H
16O) in the portion of Ibuprofen taken by the formula:
10,000(C / W)(RU / RS),
in which
C is the concentration, in mg per mL, of 4-isobutylacetophenone in the
4-Isobutylacetophenone standard solution; W is the weight, in mg, of Ibuprofen taken to prepare the
Assay preparation; and
RU and
RS are the peak response ratios of 4-isobutylacetophenone to valerophenone obtained from the
Assay preparation and the
4-Isobutylacetophenone standard solution, respectively: not more than 0.1% is found.
Assay
Mobile phase
Dissolve 4.0 g of chloroacetic acid in 400 mL of water, and adjust with ammonium hydroxide to a pH of 3.0. Add 600 mL of acetonitrile, filter, and degas. Make adjustments if necessary (see
System Suitability under
Chromatography 621).
Internal standard solution
Prepare a solution of valerophenone in Mobile phase having a concentration of about 0.35 mg per mL.
Standard preparation
Dissolve an accurately weighed quantity of
USP Ibuprofen RS in
Internal standard solution to obtain a solution having a known concentration of about 12 mg per mL.
4-Isobutylacetophenone standard solution
Quantitatively dissolve an accurately weighed quantity of 4-isobutylacetophenone in acetonitrile to obtain a solution having a known concentration of about 0.6 mg per mL. Add 2.0 mL of this stock solution to 100.0 mL of Internal standard solution, and mix to obtain a solution having a known concentration of about 0.012 mg of 4-isobutylacetophenone per mL.
Assay preparation
Transfer about 1200 mg of Ibuprofen, accurately weighed, to a 100-mL volumetric flask, dilute to volume with Internal standard solution, and mix.
Chromatographic system (see Chromatography 621)
The liquid chromatograph is equipped with a 254-nm detector and a 4.6-mm × 25-cm column that contains packing L1. The flow rate is about 2 mL per minute. Chromatograph the
Standard preparation, and record the peak responses as directed for
Procedure: the resolution,
R, between the ibuprofen and internal standard peaks is not less than 2.5, and the relative standard deviation for replicate injections is not more than 2.0%. Chromatograph the
4-Isobutylacetophenone standard solution, and record the peak responses as directed for
Procedure: the relative retention times are about 1.0 for valerophenone and 1.2 for 4-isobutylacetophenone, the tailing factors for the individual peaks are not more than 2.5, the resolution,
R, between the valerophenone peak and the 4-isobutylacetophenone peak is not less than 2.5, and the relative standard deviation for replicate injections is not more than 2.0%.
Procedure
Separately inject equal volumes (about 5 µL) of the
Standard preparation, the
Assay preparation, and the
4-Isobutylacetophenone standard solution into the chromatograph, record the chromatograms, and measure the responses for the major peaks. The relative retention times are about 1.4 for the internal standard and 1.0 for ibuprofen. Calculate the quantity, in mg, of C
13H
18O
2 in the portion of Ibuprofen taken by the formula:
100C(RU / RS),
in which
C is the concentration, in mg per mL, of
USP Ibuprofen RS in the
Standard preparation; and
RU and
RS are the peak response ratios obtained from the
Assay preparation and the
Standard preparation, respectively.